Delic’s Acquisition Target, Ketamine Infusion Centers, Announces Proposal to Acquire 2 Additional Clinic Locations May 11, 2021
Revive Therapeutics Enters Into Research Agreement with UCSF For Bucillamine As Potential Treatment For Severe COVID-19 May 3, 2021
In The Face of Emerging Research, Numinus’ Upcoming Phase One Trial Is All About Safety And Efficacy Apr 30, 2021